References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Gardineretal(2002)Complexregionalhaemodynamiceffectsofanandamideinconsciousrats.Br.J.Pharmacol.1351889PMID:11959791
Kagayaetal(2002)Characterizationoftheanandamide-induceddepolarizationofguinea-pigisolatedvagusnerve.Br.J.Pharmacol.13739PMID:12183329
Pertwee(1999)Pharmacologyofcannabinoidreceptorligands.Curr.Med.Chem.6635PMID:10469884
Rossetal(2001)Structure-activityrelationshipfortheendogenouscannabinoid,anandamide,andcertainofitsanaloguesatvanilloidreceptorsintransfectedcellsandvasdeferens.Br.J.Pharmacol.132631PMID:11159715
Rybergetal(2007)TheorphanreceptorGPR55isanovelcannabinoidreceptor.Br.J.Pharmacol.1521092PMID:17876302
Sanchoetal(2003)Anandamideinhibitsnuclearfactor-κBactivationthroughacannabinoidreceptor-independentpathway.Mol.Pharmacol.63429PMID:12527815
Keywords:Anandamide(inTocrisolve100),supplier,Endogenous,CB,agonist,water-soluble,emulsion,vanilloid,Cannabinoids,Non-Selective,Receptors,Vanillioid,VR1,TRPV,TRP,Channels,Transient,Receptor,Potential,cb2r,cb1r,Arachidonylethanolamide,AEA,Non-selective,Cannabinoids,TRPV,Non-selective,Cannabinoids,TocrisBioscience